Efficient and multiply robust estimators are proposed for counterfactual cumulative incidence curves via data fusion of historical vaccine trial and immunobridging data, including cause-specific extensions for multi-serotype pathogens.
In- fluenza vaccine effectiveness in the United States during the 2015–2016 season.New England Journal of Medicine, 377(6):534–543
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
stat.ME 1years
2026 1verdicts
UNVERDICTED 1representative citing papers
citing papers explorer
-
Efficient estimation of cumulative incidence curves via data fusion with surrogates: application to integrated analysis of vaccine trial and immunobridging data
Efficient and multiply robust estimators are proposed for counterfactual cumulative incidence curves via data fusion of historical vaccine trial and immunobridging data, including cause-specific extensions for multi-serotype pathogens.